Year: 2025
Type: dissertation
Abstract: Rapid and reliable phenotypic antibiotic susceptibility testing (AST) is essential to address the growing challenge of antimicrobial resistance. Traditional AST methods rely on detecting bacterial growth, resulting in a long sample-to-result time. This thesis addresses this limitation by developing a lab-on-a-silicon-chip (LOSC) platform that directly collects and concentrates bacteria from clinical samples, following electrically monitoring bacterial metabolism in real time, offering a rapid, label-free approach for phenotypic AST. The work begins with the development of an integration process for combining nanoscale ion-sensitive field-effect transistor (ISFET) sensors with microfluidics, including the implementation of on-chip AgCl/Ag pseudo-reference electrodes (p-REs) for ISFET operation. These p-REs are fabricated using well-established semiconductor processes and are protected with a photoresist layer to enhance their stability. Their proximity to the ISFETs minimizes streaming potential effects under varying flow rates. To further improve measurement reliability, an AC gate biasing technique is employed to suppress signal drift, enabling stable, long-term real-time monitoring. Building on this foundation, a high-throughput LOSC platform with picoliter-scale microchambers is developed to collect and concentrate bacterial cells for AST. These chambers efficiently trap cells from dilute E. coli cultures, achieving local densities around 3×108 cells/mL – sufficiently high to induce detectable pH changes from cellular metabolism. Using this setup, the LOSC platform enables rapid AST of clinical E. coli isolates with a sample-to-result time below 20 minutes. In addition to AST, this platform provides insights into bacterial metabolic responses under antibiotic exposure. We have found that the changed acidification during the first hour of ampicillin treatment is induced by altered cellular metabolism rather than cell lysis. Liquid chromatography–mass spectrometry (LC-MS) analysis identifies acetate, succinate, and pyruvate as the primary organic acids that are responsible for pH reduction. Further experiments using ΔnuoG and ΔatpA mutants reveal that disruptions in energy metabolism alter acidification dynamics and antibiotic susceptibility. ΔnuoG mutants enhance malate and fumarate secretion via the glyoxylate shunt, while ΔatpA exhibits elevated pyruvate excretion and reduced sensitivity to ampicillin, suggesting a link between the tricarboxylic acid cycle (TCA) activity and bactericidal efficacy. To improve signal robustness for point-of-care applications, a lateral bipolar junction transistor (LBJT) is integrated with a nanoribbon field-effect transistor (NRFET) sensor as an internal amplifier. This LBJT-NRFET configuration achieves a current gain of over 20 and a 3–7× improvement in signal-to-noise ratio. The LBJT-NRFET maintains high pH sensitivity and exhibits strong immunity to external interference. Moreover, the fabrication process remains fully compatible with standard semiconductor fabrication technology, supporting scalable sensor integration. In summary, this work establishes a robust and scalable LOSC platform for rapid, phenotypic AST based on bacterial metabolism. Its fully electrical readout, semiconductor process compatibility, and high sensitivity make it well-suited for future applications in clinical diagnostics and microbial physiology studies.
Author: Xu, Zheqiang
Institution: Uppsala University
Language: English
Subfield: Biomedical Engineering
Field: Engineering
Domain: Physical Sciences
Open Access status: green
Funder: Uppsala Universitet
OpenAlex ID: W7081537702
